VGNX -- Variagenics, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VGNX -- Variagenics, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (113)	2/20/2002 1:09:00 PM
From: scaram(o)uche	Read Replies (1) of 269

agan posting this link to the thread, but now copying the entire post as well. "Within a month or two" is almost past. Let's see if Crouch learned ANYTHING in that disastrous 2001.......... messages.yahoo.com Hope everyone listened to the H&Q presentation today. The Boehringer Ingelheim assays have (paraphrased, but close if not exact) "now gone into the clinic". Doesn't mean, of course, that they've got the correct genes (or correct markers, even given the correct genes). But..... big, big step. Congrats, Crouch et al.! There are two retrospective clinical proof of principle studies, one cardiovascular and one CNS. Paraphrased again..... "significantly more information coming on cardiovascular within a month of two". The CNS program? I believe is is a Japanese study on schizophrenia. Cash burn was projected to be $5-6 million per quarter.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next